MetLife Investment Management’s Protolabs PRLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.15M | Buy |
14,086
+675
| +5% | +$47.5K | 0.01% | 1453 |
|
|
2026
Q1 | $765K | Sell |
13,411
-126
| -0.9% | -$7.31K | ﹤0.01% | 1541 |
|
|
2025
Q4 | $685K | Sell |
13,537
-959
| -7% | -$49.1K | ﹤0.01% | 1643 |
|
|
2025
Q3 | $725K | Hold |
14,496
| – | – | ﹤0.01% | 1633 |
|
|
2025
Q2 | $580K | Sell |
14,496
-609
| -4% | -$22.7K | ﹤0.01% | 1603 |
|
|
2025
Q1 | $529K | Sell |
15,105
-330
| -2% | -$13K | ﹤0.01% | 1703 |
|
|
2024
Q4 | $603K | Hold |
15,435
| – | – | ﹤0.01% | 1697 |
|
|
2024
Q3 | $453K | Hold |
15,435
| – | – | ﹤0.01% | 1833 |
|
|
2024
Q2 | $477K | Buy |
15,435
+1,397
| +10% | +$44.3K | ﹤0.01% | 1741 |
|
|
2024
Q1 | $502K | Hold |
14,038
| – | – | ﹤0.01% | 1677 |
|
|
2023
Q4 | $547K | Hold |
14,038
| – | – | ﹤0.01% | 1633 |
|
|
2023
Q3 | $371K | Hold |
14,038
| – | – | ﹤0.01% | 1811 |
|
|
2023
Q2 | $491K | Hold |
14,038
| – | – | ﹤0.01% | 1703 |
|
|
2023
Q1 | $465K | Hold |
14,038
| – | – | ﹤0.01% | 1690 |
|
|
2022
Q4 | $358K | Hold |
14,038
| – | – | ﹤0.01% | 1851 |
|
|
2022
Q3 | $511K | Hold |
14,038
| – | – | ﹤0.01% | 1620 |
|
|
2022
Q2 | $672K | Hold |
14,038
| – | – | 0.01% | 1458 |
|
|
2022
Q1 | $743K | Buy |
14,038
+3,673
| +35% | +$193K | ﹤0.01% | 1521 |
|
|
2021
Q4 | $532K | Hold |
10,365
| – | – | ﹤0.01% | 1471 |
|
|
2021
Q3 | $690K | Hold |
10,365
| – | – | 0.01% | 1341 |
|
|
2021
Q2 | $952K | Hold |
10,365
| – | – | 0.01% | 1188 |
|
|
2021
Q1 | $1.26M | Sell |
10,365
-691
| -6% | -$115K | 0.01% | 1042 |
|
|
2020
Q4 | $1.7M | Hold |
11,056
| – | – | 0.02% | 907 |
|
|
2020
Q3 | $1.43M | Sell |
11,056
-616
| -5% | -$81K | 0.02% | 869 |
|
|
2020
Q2 | $1.31M | Hold |
11,672
| – | – | 0.01% | 923 |
|
|
2020
Q1 | $889K | Hold |
11,672
| – | – | 0.01% | 959 |
|
|
2019
Q4 | $1.19M | Hold |
11,672
| – | – | 0.01% | 1012 |
|
|
2019
Q3 | $1.19M | Hold |
11,672
| – | – | 0.01% | 988 |
|
|
2019
Q2 | $1.35M | Sell |
11,672
-23,344
| -67% | -$2.51M | 0.01% | 977 |
|
|
2019
Q1 | $3.68M | Buy |
35,016
+23,344
| +200% | +$2.62M | 0.01% | 974 |
|
|
2018
Q4 | $1.32M | Hold |
11,672
| – | – | 0.02% | 925 |
|
|
2018
Q3 | $1.89M | Sell |
11,672
-676
| -5% | -$95.6K | 0.02% | 884 |
|
|
2018
Q2 | $1.47M | Buy |
12,348
+1,286
| +12% | +$157K | 0.02% | 888 |
|
|
2018
Q1 | $1.3M | Hold |
11,062
| – | – | 0.02% | 911 |
|
|
2017
Q4 | $1.14M | Buy |
+11,062
| New | +$993K | 0.01% | 983 |
|
Other funds holding PRLB
DGI
ACM
MetLife Investment Management's PRLB Position: Q2 2026 in Review
MetLife Investment Management increased its Protolabs (PRLB) stake by 5% in Q2 2026, buying an estimated $47.5K and bringing the position to 14,086 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #1453.
MetLife Investment Management first reported a position in PRLB in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.68M in Q1 2019. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.
- MetLife Investment Management held 14,086 shares of Protolabs worth $1.15M as of Q2 2026.
- MetLife Investment Management bought 675 Protolabs shares in Q2 2026, an estimated $47.5K.
- Protolabs made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1453 holding.
- MetLife Investment Management first reported a position in Protolabs in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Protolabs position peaked at $3.68M in Q1 2019.
- 277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.